Conference Brief

Web Version  |  Share with a colleague   |   Digital Edition  |   Digital Edition Subscribe  |   Print Subscribe   |   eNews Subscribe

DAY 1 - Friday, Feb. 7, 2014

WELCOME

Glaucoma 360 covers all angles, all segments—all to finding a cure for glaucoma

Ophthalmology Times welcomes attendees and readers to the 3rd Annual Glaucoma 360, a series of three events uniting research, industry, and philanthropy with one mission–to find a cure for glaucoma.

Three separate events set from Thursday, Feb. 6, to Saturday, Feb. 8, at the Palace Hotel, feature the "Glaucoma 360 Annual Gala" held last night; the "New Horizons Forum" today; and the "CME Symposium," which concludes the meeting on Saturday.

The Glaucoma Research Foundation (GRF), a national nonprofit organization dedicated to finding a cure for glaucoma, is presenting Glaucoma 360. Ophthalmology Times is "The Official Partner and Media Sponsor" for the meeting. » MORE


GLAUCOMA 360 ANNUAL GALA

Venture capitalist receives Catalyst Award

Honored for his dedicated career in advancing innovative concepts to help patients preserve their vision, William J. Link, PhD, a leading venture capitalist and entrepreneur specializing in ophthalmology, received the 2014 Catalyst Award on Thursday night at the Glaucoma Research Foundation (GRF) Glaucoma 360 Annual Gala. » MORE

Catalyst for a Cure team establishes
targets for glaucoma biomarkers

Several years ago, the Glaucoma Research Foundation (GRF) expanded its initiative to advance glaucoma research through a collaborative approach by creating a second Catalyst for a Cure research team.

The new group was charged with finding biomarkers for the earliest pathologic events in glaucoma onset and progression. The four principal scientists in the Catalyst for Cure Biomarker Initiative updated attendees on their progress. » MORE

2014 Shaffer Grants for Innovative Glaucoma
Research announced during annual gala

Continuing its commitment to explore novel or promising ideas, the Glaucoma Research Foundation (GRF) announced the top selections for the 2014 Shaffer Grants for Innovative Glaucoma Research at last night's Glaucoma 360 Annual Gala.
» MORE


DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
 
Conference Brief
 

While attending the Glaucoma 360 events, stay connected by using and following #Glaucoma360

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

Advanstar Eye Health Group

mdlugoss@advanstar.com

 

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.